Bruce Cree
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis (NCT06451159) | Bruce Cree | 2024-06-20 |
Track Bruce Cree automatically
Every clearance here is in the API, with alerts when new ones post.